Menu

On Women Studying STEM

Eileen Pollack combines personal experience and data in an essay about being a woman in science.

Oct 4, 2013
Abby Olena

FLICKR, SMITHSONIAN INSTITUTIONWhen Eileen Pollack, a professor of creative writing at the University of Michigan, graduated from Yale University in 1978, she was one of the first two women to earn a bachelor’s degree in physics. In spite of excelling academically, her professors never encouraged her, and she never believed she was good enough at science to attend grad school in physics or math. In an essay published this week (October 3) by The New York Times magazine, Pollack weaves her personal story together with anecdotes and research about being a woman in science today.

“I wanted to understand why I had walked away from my dream, and why so many other women still walk away from theirs,” Pollack wrote. In interviews with female undergraduate and graduate trainees, Pollack uncovered story after story of roadblocks and scorn that young women who study science still encounter. For instance, one student reported that a physics teacher once told her that she would be graded on a curve specifically for girls, while the boys would have their own, presumably more rigorous, curve. Meg Urry, a Yale professor of physics and astronomy, told Pollack she was “flabbergasted” after hearing these stories from women in her own department.

Pollack’s personal experience and that of many of the women she spoke to focused on physics, where women earn only one fifth of the PhDs. But even in biology, where they earn more than half the PhDs, women still face discrimination. In her essay, Pollack discussed a study published in Proceedings of the National Academy of Sciences last year that revealed the subtle bias of biology, chemistry, and physics faculty against women. In the study, the professors were sent identical application materials for either “John” or “Jennifer,” candidates for a lab manager position. Both male and female science faculty ranked John above Jennifer in competence, hireability, whether the candidate was deserving of mentorship, and what salary they would offer the candidate.

Jo Handelsman, professor of cellular and molecular biology at Yale and senior author of the PNAS study, told Pollack that she was not surprised by the study’s results. “Nor was she surprised that the bias against women was as strong in biology as in physics or chemistry, despite the presence of more female biologists in most departments. Biologists may see women in their labs, [Handelsman] says, but their biases have been formed by images and attitudes they have been absorbing since birth,” wrote Pollack.

In the face of inherent biases against women scientists, Pollack makes suggestions for improvement, such as welcoming women to science relatively late and getting educators on board. “Most of all, we need to make sure that women—and men—don’t grow up in a society in which they absorb images of scientists as geeky male misfits,” she writes. “As so many studies have demonstrated, success in math and the hard sciences, far from being a matter of gender, is almost entirely dependent on culture.”

January 2019

Cannabis on Board

Research suggests ill effects of cannabinoids in the womb

Marketplace

Sponsored Product Updates

WIN a VIAFLO 96/384 to supercharge your microplate pipetting!
WIN a VIAFLO 96/384 to supercharge your microplate pipetting!
INTEGRA Biosciences is offering labs the chance to win a VIAFLO 96/384 pipette. Designed to simplify plate replication, plate reformatting or reservoir-to-plate transfers, the VIAFLO 96/384 allows labs without the space or budget for an expensive pipetting robot to increase the speed and throughput of routine tasks.
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX has announced that their digital PCR assets, including the CONSTELLATION® series of instruments, is being acquired by QIAGEN N.V. (NYSE: QGEN, Frankfurt Stock Exchange: QIA) for up to $260 million ($125 million upfront payment and $135 million of milestones).  QIAGEN has announced plans for a global launch in 2020 of a new series of digital PCR platforms that utilize the advanced dPCR technology developed by FORMULATRIX combined with QIAGEN’s expertise in assay development and automation.
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
With this application note from Taconic, learn about the power that the CRISPR/Cas system has to revolutionize the field of custom mouse model generation!
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
This webinar, from Crown Bioscience, presents a unique continuum of translational dysmetabolic platforms that more closely mimic human disease. Learn about using next-generation rodent and spontaneously diabetic non-human primate models to accurately model human-relevant disease progression and complications related to obesity and diabetes here!